{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T16:38:28Z","timestamp":1768149508720,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["project CENTRO-01-0145-FEDER-000008: BrainHealth 2020"],"award-info":[{"award-number":["project CENTRO-01-0145-FEDER-000008: BrainHealth 2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["projects POCI-01-0145-FEDER-016390: CANCEL STEM and POCI-01-0145-FEDER-007440; UIDB\/04539\/2020"],"award-info":[{"award-number":["projects POCI-01-0145-FEDER-016390: CANCEL STEM and POCI-01-0145-FEDER-007440; UIDB\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/50006\/2013"],"award-info":[{"award-number":["UID\/QUI\/50006\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/MULTI\/04378\/2013"],"award-info":[{"award-number":["UID\/MULTI\/04378\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["IF\/00092\/2014"],"award-info":[{"award-number":["IF\/00092\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/106035\/2015"],"award-info":[{"award-number":["PD\/BD\/106035\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/79077\/2011"],"award-info":[{"award-number":["SFRH\/BD\/79077\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11095-020-02904-x","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T17:02:40Z","timestamp":1599238960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lauroylated Histidine-Enriched S413-PV Peptide as an Efficient Gene Silencing Mediator in Cancer Cells"],"prefix":"10.1007","volume":"37","author":[{"given":"Catarina M.","family":"Morais","sequence":"first","affiliation":[]},{"given":"Ana M.","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Aguiar","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[]},{"given":"Cl\u00e9vio","family":"N\u00f3brega","sequence":"additional","affiliation":[]},{"given":"M\u00f3nica","family":"Zuzarte","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Maria C.","family":"Pedroso de Lima","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7095-5337","authenticated-orcid":false,"given":"Am\u00e1lia S.","family":"Jurado","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"issue":"4","key":"2904_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/nano7040077","volume":"7","author":"K Tatiparti","year":"2017","unstructured":"Tatiparti K, Sau S, Kashaw SK, Iyer AK. siRNA delivery strategies: a comprehensive review of recent developments. Nanomaterials (Basel). 2017;7(4):77.","journal-title":"Nanomaterials (Basel)"},{"issue":"11","key":"2904_CR2","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1039\/C8TB03124J","volume":"7","author":"Z Kang","year":"2019","unstructured":"Kang Z, Meng Q, Liu K. Peptide-based gene delivery vectors. J Mater Chem B. 2019;7(11):1824\u201341.","journal-title":"J Mater Chem B"},{"issue":"2","key":"2904_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/biomedicines6020051","volume":"6","author":"G McClorey","year":"2018","unstructured":"McClorey G, Banerjee S. Cell-penetrating peptides to enhance delivery of oligonucleotide-based therapeutics. Biomedicines. 2018;6(2):51.","journal-title":"Biomedicines"},{"issue":"16","key":"2904_CR4","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.2174\/1381612811319160006","volume":"19","author":"S Trabulo","year":"2013","unstructured":"Trabulo S, Cardoso AL, Cardoso AM, Morais CM, Jurado AS. Pedroso de Lima MC. Cell-penetrating peptides as nucleic acid delivery systems: from biophysics to biological applications. Curr Pharm Des. 2013;19(16):2895\u2013923.","journal-title":"Curr Pharm Des"},{"key":"2904_CR5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.peptides.2018.04.015","volume":"104","author":"A Srimanee","year":"2018","unstructured":"Srimanee A, Arvanitidou M, Kim K, H\u00e4llbrink M, Langel \u00dc. Cell-penetrating peptides for siRNA delivery to glioblastomas. Peptides. 2018;104:62\u20139.","journal-title":"Peptides."},{"key":"2904_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2017.02.003","volume":"7","author":"L P\u00e4rnaste","year":"2017","unstructured":"P\u00e4rnaste L, Arukuusk P, Langel K, Tenson T, Langel \u00dc. The formation of nanoparticles between small interfering RNA and amphipathic cell-penetrating peptides. Mol Ther Nucleic Acids. 2017;7:1\u201310.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2904_CR7","doi-asserted-by":"crossref","first-page":"19926","DOI":"10.1038\/s41598-019-56455-2","volume":"9","author":"K Kurrikoff","year":"2019","unstructured":"Kurrikoff K, Freimann K, Veiman K-L, Peets EM, Piirsoo A, Langel \u00dc. Effective lung-targeted RNAi in mice with peptide-based delivery of nucleic acid. Sci Rep. 2019;9(1):19926.","journal-title":"Sci Rep"},{"issue":"1","key":"2904_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2016.05.030","volume":"509","author":"K Konate","year":"2016","unstructured":"Konate K, Lindberg MF, Vaissiere A, Jourdan C, Aldrian G, Margeat E, et al. Optimisation of vectorisation property: a comparative study for a secondary amphipathic peptide. Int J Pharm. 2016;509(1):71\u201384.","journal-title":"Int J Pharm"},{"key":"2904_CR9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2017.04.012","volume":"256","author":"G Aldrian","year":"2017","unstructured":"Aldrian G, Vaissi\u00e8re A, Konate K, Seisel Q, Viv\u00e8s E, Fernandez F, et al. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo. J Control Release. 2017;256:79\u201391.","journal-title":"J Control Release"},{"issue":"1","key":"2904_CR10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12951-017-0269-2","volume":"15","author":"A Vaissi\u00e8re","year":"2017","unstructured":"Vaissi\u00e8re A, Aldrian G, Konate K, Lindberg MF, Jourdan C, Telmar A, et al. A retro-inverso cell-penetrating peptide for siRNA delivery. J Nanobiotechnol. 2017;15(1):34.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"2904_CR11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/acs.bioconjchem.8b00776","volume":"30","author":"K Konate","year":"2019","unstructured":"Konate K, Dussot M, Aldrian G, Vaissi\u00e8re A, Viguier V, Neira IF, et al. Peptide-based nanoparticles to rapidly and efficiently \u201cwrap \u2018n roll\u201d siRNA into cells. Bioconjug Chem. 2019;30(3):592\u2013603.","journal-title":"Bioconjug Chem"},{"issue":"2","key":"2904_CR12","doi-asserted-by":"crossref","first-page":"1900204","DOI":"10.1002\/adtp.201900204","volume":"3","author":"N Laroui","year":"2020","unstructured":"Laroui N, Cubedo N, Rossel M, Bettache N. Improvement of cell penetrating peptide for efficient siRNA targeting of tumor xenografts in zebrafish embryos. Adv Ther. 2020;3(2):1900204.","journal-title":"Adv Ther"},{"issue":"29","key":"2904_CR13","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1021\/bi0201466","volume":"41","author":"E Hariton-Gazal","year":"2002","unstructured":"Hariton-Gazal E, Feder R, Mor A, Graessmann A, Brack-Werner R, Jans D, et al. Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry. 2002;41(29):9208\u201314.","journal-title":"Biochemistry."},{"issue":"12","key":"2904_CR14","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.bbamem.2018.10.002","volume":"1860","author":"CM Morais","year":"2018","unstructured":"Morais CM, Cardoso AM, Cunha PP, Aguiar L, Vale N, Lage E, et al. Acylation of the S413-PV cell-penetrating peptide as a means of enhancing its capacity to mediate nucleic acid delivery: relevance of peptide\/lipid interactions. Biochim Biophys Acta Biomembr. 2018;1860(12):2619\u201334.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"3","key":"2904_CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/mt.2011.284","volume":"20","author":"H Margus","year":"2012","unstructured":"Margus H, Padari K, Pooga M. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther. 2012;20(3):525\u201333.","journal-title":"Mol Ther"},{"issue":"16","key":"2904_CR16","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.2174\/1381612811319160004","volume":"19","author":"K Konate","year":"2013","unstructured":"Konate K, Rydstrom A, Divita G, Deshayes S. Everything you always wanted to know about CADY-mediated siRNA delivery* (* but afraid to ask). Curr Pharm Des. 2013;19(16):2869\u201377.","journal-title":"Curr Pharm Des"},{"issue":"Pt 2","key":"2904_CR17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/BJ20050577","volume":"390","author":"M Mano","year":"2005","unstructured":"Mano M, Teodosio C, Paiva A, Simoes S. Pedroso de Lima MC. On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem J. 2005;390(Pt 2):603\u201312.","journal-title":"Biochem J"},{"issue":"7","key":"2904_CR18","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1021\/mp400078h","volume":"10","author":"AM Cardoso","year":"2013","unstructured":"Cardoso AM, Trabulo S, Cardoso AL, Maia S, Gomes P, Jurado AS. Pedroso de Lima MC. Comparison of the efficiency of complexes based on S4(13)-PV cell-penetrating peptides in plasmid DNA and siRNA delivery. Mol Pharm. 2013;10(7):2653\u201366.","journal-title":"Mol Pharm"},{"issue":"2","key":"2904_CR19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/21691401.2017.1307210","volume":"46","author":"A Singh","year":"2018","unstructured":"Singh A, Trivedi P, Jain NK. Advances in siRNA delivery in cancer therapy. Artif Cells Nanomed Biotechnol. 2018;46(2):274\u201383.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"12, Part A","key":"2904_CR20","first-page":"1865","volume":"1861","author":"RA Igal","year":"2016","unstructured":"Igal RA. Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism. Biochim Biophys Acta (BBA) \u2013 Mol Cell Biol Lipids. 2016;1861(12, Part A):1865\u201380.","journal-title":"Biochim Biophys Acta (BBA) \u2013 Mol Cell Biol Lipids"},{"issue":"7","key":"2904_CR21","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/cancers11070948","volume":"11","author":"Z Tracz-Gaszewska","year":"2019","unstructured":"Tracz-Gaszewska Z, Dobrzyn P. Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer. Cancers (Basel). 2019;11(7):948.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2904_CR22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/hmg\/dds496","volume":"22","author":"PM Costa","year":"2013","unstructured":"Costa PM, Cardoso AL, Nobrega C, Pereira de Almeida LF, Bruce JN, Canoll P, et al. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Hum Mol Genet. 2013;22(5):904\u201318.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2904_CR23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.gt.3300674","volume":"5","author":"S Simoes","year":"1998","unstructured":"Simoes S, Slepushkin V, Gaspar R, de Lima MC, Duzgunes N. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther. 1998;5(7):955\u201364.","journal-title":"Gene Ther"},{"issue":"1","key":"2904_CR24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijpharm.2014.07.019","volume":"473","author":"D Farinha","year":"2014","unstructured":"Farinha D. Pedroso de Lima MC, Faneca H. specific and efficient gene delivery mediated by an asialofetuin-associated nanosystem. Int J Pharm. 2014;473(1):366\u201374.","journal-title":"Int J Pharm"},{"issue":"3","key":"2904_CR25","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","volume":"1","author":"V Vichai","year":"2006","unstructured":"Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112\u20136.","journal-title":"Nat Protoc"},{"issue":"21","key":"2904_CR26","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1093\/hmg\/ddz152","volume":"28","author":"CM Morais","year":"2019","unstructured":"Morais CM, Cunha PP, Melo T, Cardoso AM, Domingues P, Domingues MR, et al. Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma. Hum Mol Genet. 2019;28(21):3664\u201379.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"2904_CR27","doi-asserted-by":"crossref","first-page":"45e","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):45e.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2904_CR28","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1093\/nar\/gkr072","volume":"39","author":"K Ezzat","year":"2011","unstructured":"Ezzat K, Andaloussi SE, Zaghloul EM, Lehto T, Lindberg S, Moreno PM, et al. PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation. Nucleic Acids Res. 2011;39(12):5284\u201398.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2904_CR29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbamem.2013.01.011","volume":"1828","author":"P Arukuusk","year":"2013","unstructured":"Arukuusk P, P\u00e4rnaste L, Oskolkov N, Copolovici D-M, Margus H, Padari K, et al. New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids. Biochim Biophys Acta Biomembr. 2013;1828(5):1365\u201373.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"16","key":"2904_CR30","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddz099","volume":"28","author":"AMS Cardoso","year":"2019","unstructured":"Cardoso AMS, Sousa M, Morais CM, Oancea-Castillo LR, R\u00e9gnier-Vigouroux A, Rebelo O, et al. MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy. Hum Mol Genet. 2019;28(16):2738\u201351.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2904_CR31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1158\/1541-7786.MCR-11-0126","volume":"9","author":"UV Roongta","year":"2011","unstructured":"Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, Henley BJ, et al. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res. 2011;9(11):1551\u201361.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"2904_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/nnm.13.204","volume":"9","author":"HY Xue","year":"2014","unstructured":"Xue HY, Liu S, Wong HL. Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (London). 2014;9(2):295\u2013312.","journal-title":"Nanomedicine (London)"},{"issue":"1","key":"2904_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajps.2014.08.011","volume":"10","author":"C-f Xu","year":"2015","unstructured":"Xu C-f, Wang J. Delivery systems for siRNA drug development in cancer therapy. Asian J Pharm Sci. 2015;10(1):1\u201312.","journal-title":"Asian J Pharm Sci"},{"issue":"2","key":"2904_CR34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0005-2736(99)00225-4","volume":"1463","author":"C Tros de Ilarduya","year":"2000","unstructured":"Tros de Ilarduya C, Duzgunes N. Efficient gene transfer by transferrin lipoplexes in the presence of serum. Biochim Biophys Acta. 2000;1463(2):333\u201342.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2904_CR35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/cbdd.12052","volume":"80","author":"M Gooding","year":"2012","unstructured":"Gooding M, Browne LP, Quinteiro FM, Selwood DL. siRNA delivery: from lipids to cell-penetrating peptides and their mimics. Chem Biol Drug Des. 2012;80(6):787\u2013809.","journal-title":"Chem Biol Drug Des"},{"key":"2904_CR36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fphar.2019.00444","volume":"10","author":"IV Chernikov","year":"2019","unstructured":"Chernikov IV, Vlassov VV, Chernolovskaya EL. Current development of siRNA bioconjugates: from research to the clinic. Front Pharmacol. 2019;10:444.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2904_CR37","doi-asserted-by":"crossref","first-page":"1801458","DOI":"10.1002\/advs.201801458","volume":"6","author":"A Hernandez-Garcia","year":"2019","unstructured":"Hernandez-Garcia A, \u00c1lvarez Z, Simkin D, Madhan A, Pariset E, Tantakitti F, et al. Peptide\u2013siRNA supramolecular particles for neural cell transfection. Adv Sci. 2019;6(3):1801458.","journal-title":"Adv Sci"},{"issue":"6","key":"2904_CR38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/pharmaceutics11060261","volume":"11","author":"AA Egorova","year":"2019","unstructured":"Egorova AA, Shtykalova SV, Maretina MA, Sokolov DI, Selkov SA, Baranov VS, et al. Synergistic anti-angiogenic effects using peptide-based combinatorial delivery of siRNAs targeting VEGFA, VEGFR1, and endoglin genes. Pharmaceutics. 2019;11(6):261.","journal-title":"Pharmaceutics"},{"issue":"5","key":"2904_CR39","volume":"9","author":"M Jafari","year":"2014","unstructured":"Jafari M, Xu W, Pan R, Sweeting CM, Karunaratne DN, Chen P. Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery. PLoS One. 2014;9(5):e97797.","journal-title":"PLoS One"},{"issue":"2","key":"2904_CR40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/mp400446v","volume":"11","author":"P Youn","year":"2014","unstructured":"Youn P, Chen Y, Furgeson DY. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery. Mol Pharm. 2014;11(2):486\u201395.","journal-title":"Mol Pharm"},{"issue":"4","key":"2904_CR41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1039\/C8MH00392K","volume":"5","author":"W Li","year":"2018","unstructured":"Li W, Wang D, Shi X, Li J, Ma Y, Wang Y, et al. A siRNA-induced peptide co-assembly system as a peptide-based siRNA nanocarrier for cancer therapy. Mater Horiz. 2018;5(4):745\u201352.","journal-title":"Mater Horiz"},{"issue":"1","key":"2904_CR42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2012.11.037","volume":"441","author":"S Lindberg","year":"2013","unstructured":"Lindberg S, Mu\u00f1oz-Alarc\u00f3n A, Helmfors H, Mosqueira D, Gyllborg D, Tudoran O, et al. PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors. Int J Pharm. 2013;441(1):242\u20137.","journal-title":"Int J Pharm"},{"issue":"1","key":"2904_CR43","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1038\/s41598-017-06381-y","volume":"7","author":"M Sharma","year":"2017","unstructured":"Sharma M, El-Sayed NS, Do H, Parang K, Tiwari RK, Aliabadi HM. Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates. Sci Rep. 2017;7(1):6093.","journal-title":"Sci Rep"},{"issue":"7","key":"2904_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068305","volume":"8","author":"SK Misra","year":"2013","unstructured":"Misra SK, Biswas J, Kondaiah P, Bhattacharya S. Gene transfection in high serum levels: case studies with new cholesterol based cationic gemini lipids. PLoS One. 2013;8(7):e68305.","journal-title":"PLoS One"},{"issue":"12","key":"2904_CR45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.7150\/thno.8491","volume":"4","author":"CA Hong","year":"2014","unstructured":"Hong CA, Nam YS. Functional nanostructures for effective delivery of small interfering RNA therapeutics. Theranostics. 2014;4(12):1211\u201332.","journal-title":"Theranostics."},{"issue":"14","key":"2904_CR46","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/smll.201102413","volume":"8","author":"S Deshayes","year":"2012","unstructured":"Deshayes S, Konate K, Rydstrom A, Crombez L, Godefroy C, Milhiet PE, et al. Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines. Small. 2012;8(14):2184\u20138.","journal-title":"Small."},{"key":"2904_CR47","doi-asserted-by":"crossref","first-page":"44134","DOI":"10.1038\/srep44134","volume":"7","author":"D Pezzoli","year":"2017","unstructured":"Pezzoli D, Giupponi E, Mantovani D, Candiani G. Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation. Sci Rep. 2017;7:44134.","journal-title":"Sci Rep"},{"key":"2904_CR48","doi-asserted-by":"crossref","first-page":"37849","DOI":"10.1038\/srep37849","volume":"6","author":"T Nakamura","year":"2016","unstructured":"Nakamura T, Kuroi M, Fujiwara Y, Warashina S, Sato Y, Harashima H. Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines. Sci Rep. 2016;6:37849.","journal-title":"Sci Rep"},{"issue":"4","key":"2904_CR49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.stemcr.2019.02.012","volume":"12","author":"K Pinkham","year":"2019","unstructured":"Pinkham K, Park DJ, Hashemiaghdam A, Kirov AB, Adam I, Rosiak K, et al. Stearoyl CoA desaturase is essential for regulation of endoplasmic reticulum homeostasis and tumor growth in glioblastoma cancer stem cells. Stem Cell Rep. 2019;12(4):712\u201327.","journal-title":"Stem Cell Rep"},{"key":"2904_CR50","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3389\/fphar.2017.00960","volume":"8","author":"S Dai","year":"2018","unstructured":"Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, et al. SCD1 confers temozolomide resistance to human glioma cells via the Akt\/GSK3\u03b2\/\u03b2-catenin signaling axis. Front Pharmacol. 2018;8:960.","journal-title":"Front Pharmacol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02904-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-020-02904-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02904-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T02:01:27Z","timestamp":1630720887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-020-02904-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1007\/s11095-020-02904-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"188"}}